Mesenchymal stem cells (MSCs) have emerged as an attractive alternative to modulating immune response after transplantation. Recent studies have shown that systemically administered MSCs enter the inflamed intestine. In the present study, we propose a strategy to improve the efficacy of MSC-based cellular therapy for inflammation using Astragaloside and Baicalein to enhance cell survival, inhibit apoptosis, and modulate inflammatory response in vitro.
Background
Mesenchymal stem cells (MSCs) have emerged as an attractive model for cell therapy for inflammatory and autoimmune diseases. MSCs are multipotent stem cells that can differentiate into different cell types [1, 2] . To ensure that MSCs reach the damaged mucosa lesions, sufficient MSCs in the peripheral blood circulation are needed for MSCs transplantation for autoimmune diseases. Recent studies have shown that some Traditional Chinese Medicines and their extracts can stimulate MSCs proliferation and differentiation [3] [4] [5] [6] , such as ozone, which can promote MSCs in intestinal tissue [7, 8] .
Our former studies showed that both Astragaloside and Baicalin can promote MSCs to move to damaged intestine tissues, in which case more MSCs home to the site of damage to support repair of the gut mucosal barrier (data not shown). However, MSCs are relatively unable to effectively promote the rebuilding of intermucosal barrier, as intestinal bacteria have negative effects on MSCs in the injured intestine [9] . Therefore, maintaining the differentiation capacity of MSCs and improving their proliferation are of significance to the treatment of ulcerative colitis. In the present study, we propose a hypothesis that Astragaloside and Baicalin enhance cell survival, inhibit apoptosis, and regulate inflammation of LPS-induced MSCs in vitro.
Material and Methods

Material
Male Sprague-Dawley rats aged 6 weeks were purchased from the animal facility of Nanjing Medical University Experimental Animal Center.
Astragaloside (20 mg, FY13081102) and Baicalin (20 mg, FY12960708) were purchased from Nanjing Feiyu Biological Technology Company.
Methods
MSCs isolation and cultivation
MSCs were isolated and cultured as described below. Briefly, 6-week-old adult mice (n=4) were mildly anesthetized using sodium pentobarbital (100 mg/kg, i.p.). Their femoral bones were obtained aseptically, then soaked in 75% ethanol for 10 min. Bone marrow cell suspension was obtained by flushing the marrow cavity with phosphate-buffered saline (PBS). The bone marrow cell suspension was aspirated and then centrifuged at 1500 rpm for 5 min. The marrow supernatant was discarded. The obtained marrow cells were then suspended in M199 medium containing 10% FBS and 1% double antibody.
The marrow suspension was seeded into culture flasks. Next, the cells were incubated for 24 h at 37°C in an atmosphere of 5% humidified CO 2 . The medium was changed every 3-4 days until MSCs reached 80% confluence. MSCs were used for experiments within passages 3-6.
Identification of MSCs
MSCs were digested with 0.25% trypsin and then centrifuged at 1000 rpm for 5 min. The supernatant was decanted. The centrifuge tubes were washed 2 times with PBS to produce the cell suspension (1×10 6 /L). The cell suspension was added into 2 tubes. Each tube, containing 0.1 ml cell suspension, was treated with either 20 ul PE-labeled CD45 or CD90 antibody. Both were incubated for 30 min at room temperature in the dark, and analyzed using flow cytometry after centrifugation.
LPS-induced MSCs preparation and experimental design
For LPS-induced MSCs preparation, after the bone marrow cell suspension was aspirated, the obtained cells were rinsed with PBS for 3 times and then shifted into serum-free medium containing 500 ng/ml LPS. Next, the cells were incubated for 24 h before supernatant collection.
MSCs were randomly assigned to the following 4 groups: the Baicalin group, the Astragaloside group, the combination group, and the control group. LPS-induced MSCs were incubated in cultures containing Astragaloside and Baicalin at concentrations of 0 ng/ml, 5 ng/ml, 10 ng/ml, 50 ng/ml, 100 ng/ml, and 500 ng/ml. The experimental effects were examined at 24 h and 48 h after treatment.
Assessment of MSCs proliferation
After incubation for 24 h and 48 h, MSCs were digested with 0.25% trypsin (containing no EDTS) and then washed with PBS by centrifugation at 2000 rpm for 5 min. MSCs ( 5×10 5 ) were collected. The single-cell suspension was fixed with 70% ethanol for 2 h (or overnight) at 4°C. After washing, 100 μL of RNase was added and incubated at 37°C for 30 min. The cells were stained with 400 μL of PI in the dark for 30 min at 37°C. The cells were analyzed using flow cytometry.
The single-cell suspension was seeded into 6-well cell culture plates and then incubated with MTT solution, with DMSO as a blank control. The sample was detected using microplate spectrophotometer absorbance.
into the culture wells. After gently shaking, the cells were assessed using annexin-V fluorescein isothiocyanate (FITC)/ propidium iodide (PI) assay and analyzed by flow cytometry.
Enzyme-linked immunosorbent assay (ELISA)
The amounts of tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6), and interleukin-1b in the culture medium supernatants were measured with a commercial ELISA kit purchased from R&D Systems (R&D Systems, USA) according to the instructions.
Assessment of inflammatory cytokines with real-time fluorescence quantitative polymerase chain reaction (qPCR)
RNA extraction was carried out using the Trizol extraction kit according to the manufacturer's instructions, and the purified RNA samples were stored at -80°C until being used. cDNAs were produced by retrograde transcription using Accupower, RocketScript, and RT PreMix commercial kits. Specific DNA fragments were amplified using RealMasterMix (Probe) and miRcute miRNA with a Stratagene cycler. The following forward (F) and reverse (R) primers were used for qPCR amplifications (synthesized by Bioneer China): IL-8-F: CCGGGGCCCGCAAGGTCATC, IL-8-R: CCACTTGTCCCGGGCATAG; IL-1b-F: CAACTCCATGTTTCATAAC, IL-1b-R: CGTGGTCTAACTTGTTGGC; TNF-a-F: CGTGAAGAACGACCTAAC; TNF-a-R: CATGTATCTTGCAGTTCC.
Assessment of inflammatory cytokines with Western blot analysis
Total proteins were separated on 10% SDS-PAGE gels and transferred onto polyvinylidene fluoride membranes (Millipore, Billerica, MA, USA). The membranes were blocked with 5% milk and incubated with primary antibodies against IL-8, L-1b, and TNF-a, as well as GAPDH, at 4°C overnight and then incubated with secondary antibody at room temperature for 1 h. The bands were visualized by enhanced chemiluminescence (Millipore, Billerica, MA, USA) and GAPDH was used as a loading control. All data analyses were repeated 3 times independently.
Statistical analysis
Data analysis was performed using SPSS version 17.0 for Windows. The Pearson's chi-squared test was used to compare qualitative variables, and comparisons among different groups were performed using one-way analysis of variance. A two-tailed P value test was used in all analyses, and a p value less than 0.05 was considered statistically significant. All experiments presented here were performed independently at least 3 times.
Results
MSCs identification
The MSCs were positive for CD90 and negative for CD45 (Figure 1 ). 
MSCs proliferation and differentiation
MTT assay was used to observe the MSCs proliferation; when drug concentration reached 100 ng/ml, the proliferation ability was obvious. The combination group had the best cell proliferation ability, followed by the Astragaloside group. At the drug concentration of 100 ng/ml, the cells grew more when incubated for 48 h than for 24 h (Figure 2 ). 
MSCs Apoptosis
The annexin-V-positive LPS-stimulated MSCs were detected by flow cytometry. The apoptotic cells were increased compared with the normal MSCs group. Compared to the LPS group, those in the drug groups were significantly reduced (P<0.01). Furthermore, although the number of apoptotic cells in the Baicalin group or Astragaloside group was higher compared with the LPS group, there was no significant difference between the 2 groups. The combination group had fewer apoptotic cells compared to the LPS group (P<0.01) ( Figure 5 ).L2 MSCs inflammation and the possible mechanism It has been established that the MAPK/ERK pathway is a major contributor to cell proliferation. To investigate how Astragaloside and Baicalin promote cell proliferation and differentiation, as well as how they inhibit MSCs apoptosis and influence the expression of the inflammatory cytokines, MAPK/ERK pathway inhibitor U0126 was used as a control. IL-8, IL-1b, and TNF-a expression were detected using ELISA, RT-PCR, and Western blot. The results showed that, compared with the combination group, the inhibitor group recovered inflammation ( Figure 6 ).
Discussion
Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, and adipocytes [10, 11] . MSCs can be easily isolated, cultured, and expanded in vitro, maintaining their biological properties, such as proliferative capacity and differentiation potential. Owing to their properties, MSCs transplantation has been used for the treatment of various diseases [12] [13] [14] . Although recent studies have shown that systemically delivered MSCs can locate in inflamed intestinal tissues, the results are far from satisfactory. Indeed, we have to isolate and expand MSCs in vitro to improve the efficacy of MSCs treatment because they are limited in number, only accounting for about 0.001~0.01% of the nucleated cells derived from bone marrow. Besides, only a few MSCs survive and settle to the site of damage. A study reported that only 0.13% of human MSCs homed to the intestine at 3 days after the injection of the cells into sublethally irradiated mice [15] [16] [17] . Therefore, suppressing apoptosis is important to effectively ameliorate the inflammatory response [18] [19] [20] .
Astragaloside, a main active substance of Astragalus, has many pharmacological functions, such as anti-virus and anti-tumor effects. Studies have shown that Astragaloside can promote MSCs proliferation and differentiation, while decreasing apoptosis. Baicalin, extracted from the root of Scutellaria, has bactericidal, anti-inflammatory, antioxidant, antispasmodic, and anti-tumor effects. Recent studies have shown that Baicalin can also promote cell proliferative capacity and differentiation potential. However, the effects of Astragaloside and Baicalin on MSCs under inflammatory conditions have not been reported in detail thus far [21] [22] [23] [24] . Patients with ulcerative colitis always have disordered intestinal flora. LPS, derived from the outer membrane of gramnegative bacteria, can induce MSCs to differentiate into inflammatory cells and secrete inflammatory cytokines [9] . Both Astragaloside and Baicalin can promote MSCs to locate in damaged intestine. However, how to increase the number of MSCs in the damaged intestine and how to suppress the differentiation of MSCs to inflammatory cells remained to be studied.
In this study, we treated MSCs with LPS to induce the inflammation model. Flow cytometry analysis showed that LPS-induced MSCs cell cycle was arrested at G1 phase, and cell apoptosis was enhanced. MTT results indicated that their proliferative potential was suppressed due to the cell cycle arrest and enhanced apoptosis. We also found that LPS-induced MSCs had some morphologic similarities to inflammation cells under the microscope. The data revealed that the expression of IL-1b, IL-8, and TNF-a were increased. In fact, the cytokines contribute to the accumulation and activation of inflammatory cells, as they can facilitate the release of inflammatory mediators, which exacerbate inflammation.
A previous study revealed that Astragaloside increased T lymphocyte and B lymphocyte proliferation, while inhibiting production of IL-1b and TNF-a from macrophages in vitro [25] . Also, Baicalin has an anti-fibrosis effect on bleomycin-induced pulmonary fibrosis [26] . Similar phenomena were also observed in our study. After the addition of the drugs, their proliferation ability was recovered, the cell apoptosis was suppressed, the expression levels of the inflammatory factors were inhibited, and LPS-induced MSCs were obviously differentiated into epithelial cells. All this further demonstrates that both Astragaloside and Baicalin can reduce the cells apoptosis while promoting cell proliferation. Therefore, they also help to differentiate LPS-treated MSCs into epithelial cells to repair injured tissue in patients with ulcerative colitis.
The MAPK/ERK pathway has been reported to be involved in many pharmacological functions induced by Baicalin and Astragaloside, including cell proliferation and apoptosis [24] [25] [26] [27] [28] . Therefore, we analyzed the function of the MAPK/ERK pathway in this study. When we treated the cells with U0126, which is a MAPK/ERK pathway inhibitor, we found that U0126 can recover the effects of Astragaloside and Baicalin on cytokines 3215 
Conclusions
We presented experimental evidence that Astragaloside and Baicalin can promote epithelial differentiation and cell growth, and reduce apoptosis and inflammatory effects.
